How gene activity affects energy and liver health in diabetes

Epigenetic Regulation of Mitochondrial Homeostasis and Energy Metabolism

['FUNDING_R01'] · UNIVERSITY OF CALIFORNIA-IRVINE · NIH-11126789

This project looks at how changes in gene activity in the liver contribute to conditions like fatty liver disease and insulin resistance, which are linked to type 2 diabetes.

Quick facts

Phase['FUNDING_R01']
Study typeNih_funding
SexAll
SponsorUNIVERSITY OF CALIFORNIA-IRVINE (nih funded)
Locations1 site (IRVINE, UNITED STATES)
Trial IDNIH-11126789 on ClinicalTrials.gov

What this research studies

Our bodies have ways to turn genes on and off, which can affect how our liver processes energy and fats. When these processes go awry, it can lead to conditions like non-alcoholic fatty liver disease (NAFLD) and insulin resistance, both key factors in type 2 diabetes. We are exploring specific gene "switches" in liver cells from both mice and people with NAFLD to understand how they contribute to these conditions. By identifying key regulators of these gene switches, we hope to uncover new ways to address the root causes of these metabolic problems.

Who could benefit from this research

Good fit: This foundational work is not directly recruiting patients but focuses on understanding the underlying biology of adult-onset diabetes mellitus and related liver conditions.

Not a fit: Patients seeking immediate treatment options or direct clinical intervention would not find direct benefit from this basic science investigation.

Why it matters

Potential benefit: If successful, this work could lead to new ways to understand and potentially treat non-alcoholic fatty liver disease and insulin resistance, offering new hope for people with type 2 diabetes.

How similar studies have performed: While the specific epigenetic mechanisms are still being mapped, the broader field of epigenetics has shown promise in understanding disease development.

Where this research is happening

IRVINE, UNITED STATES

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.

View on NIH RePORTER →

Conditions: Adult-Onset Diabetes Mellitus

Last reviewed 2026-05-15 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.